Computational Design and Synthesis of Novel Fluoro-Analogs of Combretastatins A-4 and A-1.
Computational Design and Synthesis of Novel Fluoro-Analogs of Combretastatins A-4 and A-1.
复制标题
Combretastatins A-4 和 A-1 新型氟类似物的计算设计和合成。
DOI:
10.1016/j.jfluchem.2017.09.007
复制
发表时间:
2017
影响因子:
1.9
通讯作者:
Ojima,Iwao
中科院分区:
文献类型:
--
作者:
Zong,Yao;Shea,Christie;Maffucci,Katherine;Ojima,Iwao
Combretastatin A-1 (CA-1) and combretastatin A-4 (CA-4) isolated from the African bush willowCombretum caffrumare highly potent tubulin polymerization inhibitors, possessing strong antitumor activities because of their vascular disrupting properties. Extensive SAR studies have been done for CA-4 analogs. Because of poor solubility, water-soluble prodrugs of CA-4 and CA-1 have been developed, which are currently in human clinical trials. Fluorine plays an important role in the current drug discovery and development due to its unique properties. Thus, several fluorine-containing analogs of CA-4/CA-1 have been studied. However, no analogs, which have a CF3O-, CF2HO- or CF3- group instead of the 4′-methoxy group in the B ring, have been investigated. Therefore, we set out to design and synthesize those novel fluoro-analogs of CA-4/CA-1. For the design of the new analogs, we took a structure-based design approach based on the X-ray crystal structure of colchicine-tubulin complex (PDB: 4O2B) and computational docking analysis using the AutoDock Vina program. A library of novel fluoro-analogs of CA-4/CA-1 was generated and their docking energy scores obtained. It was found that those novel fluoro-analogs exhibited better docking energy scores than CA-4/CA-1. Also, docking poses of all of these fluoro-analogs were virtually superimposable and very good fit to the colchine binding site. Among 15 compounds designed and analyzed, we have synthesized 5 compounds and evaluated their cytotoxicity against drug-sensitive and multidrug-resistant cancer cell lines. All fluoro-analogs exhibited strong cytotoxicity even against multidrug-resistant cell line. However, the critical activity of this class of compounds is its vascular disrupting activity. Thus, further biological evaluations are warranted for those novel fluoro-analogs of CA-4/CA-1.